BATS BZX Real-Time Price
As of 3:57pm ET
| -0.26 / -0.97%|
The 9 analysts offering 12-month price forecasts for Horizon Therapeutics PLC have a median target of 35.00, with a high estimate of 38.00 and a low estimate of 32.00. The median estimate represents a +32.53% increase from the last price of 26.41.
The current consensus among 9 polled investment analysts is to Buy stock in Horizon Therapeutics PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.